CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 901024039
- Phone
- 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 70 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-06 | McDowell Caryn Gordon Chief Legal & Adm. Officer | Shares withheld for taxes | −6,700 | $2.86 | $19K | 133,300 |
| 2022-06-06 | McDowell Caryn Gordon Chief Legal & Adm. Officer | Sale | −10,800 | $2.86 | $31K | 122,500 |
| 2022-05-23 | Thye Dirk Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +1,979,650 | 1,979,650 | ||
| 2022-05-23 | Smith Karen L. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +1,365,449 | 1,365,449 | ||
| 2022-05-23 | Hannah Brendan Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +353,656 | 353,656 | ||
| 2022-05-19 | Smith Karen L. Chief Medical Officer | Grant or award | +170,354 | 194,690 | ||
| 2022-05-19 | Thye Dirk Chief Executive Officer | Grant or award | +216,322 | 280,911 | ||
| 2022-05-19 | Hannah Brendan Chief Business Officer | Grant or award | +113,569 | 129,793 | ||
| 2022-05-19 | Thye Dirk Chief Executive Officer | Grant or award | +64,589 | 64,589 | ||
| 2022-05-19 | Thye Dirk Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +206,391 | 206,391 | ||
| 2022-05-19 | Smith Karen L. Chief Medical Officer | Grant or award | +24,336 | 24,336 | ||
| 2022-05-19 | Smith Karen L. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +151,799 | 151,799 | ||
| 2022-05-19 | Low Philip S Director | Grant or award | +455,309 | 455,309 | ||
| 2022-05-19 | Low Philip S Director | Grant or award | +63,974 | 63,974 | ||
| 2022-05-19 | Low Philip S Director | Grant or award · Stock Option (right to buy) | +22,058 | 22,058 | ||
| 2022-05-19 | Lamond David Director | Grant or award | +200,002 | 1,734,722 | ||
| 2022-05-19 | Hannah Brendan Chief Business Officer | Grant or award | +16,224 | 16,224 | ||
| 2022-05-19 | Hannah Brendan Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +103,500 | 103,500 | ||
| 2022-03-14 | Sabbagh Marwan Director | Grant or award · Stock Option (right to buy) | +22,058 | 22,058 | ||
| 2022-03-03 | Monohon Ted Chief Accounting Officer & VP | Grant or award | +34,000 | 34,000 |
Page 7 of 8 · 149 trades